{"id":782972,"date":"2023-09-11T07:14:50","date_gmt":"2023-09-11T11:14:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/"},"modified":"2023-09-11T07:14:50","modified_gmt":"2023-09-11T11:14:50","slug":"paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/","title":{"rendered":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System"},"content":{"rendered":"

<\/p>\n

Paragon 28\u00ae<\/sup>, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System<\/b><\/p>\n

ENGLEWOOD, Colo.–(BUSINESS WIRE<\/a>)–
\nParagon 28, Inc. (NYSE: FNA), announced today they have received an Investigational Device Exemption (IDE) approval from the FDA to commence a feasibility study for configurations of the SMART Total Talus\u2122 System used in conjunction with the Paragon 28\u00ae<\/sup> APEX 3D\u2122 Total Ankle Replacement System. The study is expected to begin in early 2024.<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230911941461\/en\/<\/a><\/p>\n

\"Paragon<\/p>\n

Paragon 28\u2019s first in the world 3D-printed Patient Specific Talus Spacer. Use in treatment of avascular necrosis (AVN). FDA approval: February 17, 2021 through an approval order for a Humanitarian Device Exception (\u201cHDE\u201d). (Graphic: Business Wire)<\/p>\n<\/div>\n

\nThis milestone is an important achievement in the advancement of Paragon 28\u2019s SMART 28\u2120strategy, which targets to provide meaningful options to their surgeon customers and significantly improve patient outcomes. The IDE of the SMART Total Talus adds to the company\u2019s existing Patient Specific Total Talus offering by expanding use of the technology as an option for prospective total ankle replacement candidates.<\/p>\n

\nParagon 28 acquired Additive Orthopaedics in June 2021, providing the Company with the first and only FDA approved Patient Specific Total Talus replacement for treatment of avascular necrosis (AVN). With approval of the IDE to support future regulatory applications, the company\u2019s SMART Total Talus is on the path to become the only device on the market intended for talar replacement in the setting of adjacent joint arthritis.<\/p>\n

\nParagon 28\u2019s CEO, Albert DaCosta, commented, \u201cThe approval of this IDE study is another great example of our commitment to improve the lives of patients suffering from foot and ankle conditions, and it is an important advancement for our SMART 28ecosystem and total ankle portfolio. We are very pleased that the FDA has recognized the potential benefits of expanding access of this technology to more ankle patients, and we are excited to get this IDE study underway.\u201d<\/p>\n

\nParagon 28 extends its gratitude to the FDA for their guidance throughout this IDE approval process and looks forward to further collaboration with the FDA and healthcare professionals and institutions participating in the IDE study.<\/p>\n

About Paragon 28, Inc.<\/b><\/p>\n

\nBased in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28\u00ae<\/sup> has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230911941461\/en\/<\/a><\/span><\/p>\n

\nInvestor Contact:
\n
Matt Brinckman
\n
Senior Vice President, Strategy and Investor Relations
\n
(720) 912-1332
\n
mbrinckman@paragon28.com<\/a><\/p>\n

KEYWORDS:<\/b> Colorado United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> FDA Health Medical Devices<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Paragon 28\u2019s first in the world 3D-printed Patient Specific Talus Spacer. Use in treatment of avascular necrosis (AVN). FDA approval: February 17, 2021 through an approval order for a Humanitarian Device Exception (\u201cHDE\u201d). (Graphic: Business Wire)<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Paragon 28\u2019s SMART Total Talus System. Use in conjunction with APEX Total Ankle Replacement System as a replacement for a talus with adjacent joint arthritis, spanning a broad array of pathologies. FDA approval of IDE Study: August 30th, 2023. (Graphic: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System ENGLEWOOD, Colo.–(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA), announced today they have received an Investigational Device Exemption (IDE) approval from the FDA to commence a feasibility study for configurations of the SMART Total Talus\u2122 System used in conjunction with the Paragon 28\u00ae APEX 3D\u2122 Total Ankle Replacement System. The study is expected to begin in early 2024. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230911941461\/en\/ Paragon 28\u2019s first in the world 3D-printed Patient Specific Talus Spacer. Use in treatment of avascular necrosis (AVN). FDA approval: February 17, 2021 through … <\/p>\n

Continue reading “Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-782972","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nParagon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System ENGLEWOOD, Colo.–(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA), announced today they have received an Investigational Device Exemption (IDE) approval from the FDA to commence a feasibility study for configurations of the SMART Total Talus\u2122 System used in conjunction with the Paragon 28\u00ae APEX 3D\u2122 Total Ankle Replacement System. The study is expected to begin in early 2024. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230911941461\/en\/ Paragon 28\u2019s first in the world 3D-printed Patient Specific Talus Spacer. Use in treatment of avascular necrosis (AVN). FDA approval: February 17, 2021 through … Continue reading "Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-11T11:14:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230911941461\/en\/1886005\/4\/PARAGON-28-Picture2.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System\",\"datePublished\":\"2023-09-11T11:14:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/\"},\"wordCount\":620,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230911941461\\\/en\\\/1886005\\\/4\\\/PARAGON-28-Picture2.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/\",\"name\":\"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230911941461\\\/en\\\/1886005\\\/4\\\/PARAGON-28-Picture2.jpg\",\"datePublished\":\"2023-09-11T11:14:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230911941461\\\/en\\\/1886005\\\/4\\\/PARAGON-28-Picture2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230911941461\\\/en\\\/1886005\\\/4\\\/PARAGON-28-Picture2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/","og_locale":"en_US","og_type":"article","og_title":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System - Market Newsdesk","og_description":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System ENGLEWOOD, Colo.–(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA), announced today they have received an Investigational Device Exemption (IDE) approval from the FDA to commence a feasibility study for configurations of the SMART Total Talus\u2122 System used in conjunction with the Paragon 28\u00ae APEX 3D\u2122 Total Ankle Replacement System. The study is expected to begin in early 2024. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230911941461\/en\/ Paragon 28\u2019s first in the world 3D-printed Patient Specific Talus Spacer. Use in treatment of avascular necrosis (AVN). FDA approval: February 17, 2021 through … Continue reading \"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-11T11:14:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230911941461\/en\/1886005\/4\/PARAGON-28-Picture2.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System","datePublished":"2023-09-11T11:14:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/"},"wordCount":620,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230911941461\/en\/1886005\/4\/PARAGON-28-Picture2.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/","name":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230911941461\/en\/1886005\/4\/PARAGON-28-Picture2.jpg","datePublished":"2023-09-11T11:14:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230911941461\/en\/1886005\/4\/PARAGON-28-Picture2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230911941461\/en\/1886005\/4\/PARAGON-28-Picture2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paragon-28-inc-receives-fda-approval-for-ide-feasibility-study-of-its-smart-total-talus-system-for-use-in-conjunction-with-the-apex-3d-total-ankle-replacement-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Paragon 28\u00ae, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus\u2122 System for use in Conjunction with the APEX 3D\u2122 Total Ankle Replacement System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=782972"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782972\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=782972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=782972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=782972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}